IL17A and psoriasis: In an experimental model of psoriasis-like inflammation in mice using the TLR7-agonist imiquimod, dermal Vγ4+ γδ T cells persist in the skin and contribute to skin inflammation by producing IL-17A and IL-17F51,52.